SANTA CLARA, Calif.--DiaDexus, a joint venture between Smith Kline Beecham and Incyte pharmaceuticals here, announced the formation of its scientific advisory board. The company is dedicated to the discovery and commercialization of novel molecular diagnostic products focused on disease detection. Major research areas include oncology, microbiology, and pharmacogenomics.
Appointees to the advisory board include Arthur Beaudet of the Department of Molecular and Human Genetics at Baylor College of Medicine; Isaiah Fidler, chairman of the Department of Cell Biology at the University of Texas; Herbert Fritsche, chief of clinical chemistry at the University of Texas; Lynn Burgess of the Department of Human Genetics at the University of Utah College of Medicine; Edward Kaplan, professor of pediatrics at the University of Minnesota; Stephen Morse of the Centers for Disease Control and Prevention; Martin Rosenberg, senior vice-president and director antiinfectives research at SmithKline Beecham; and Morton Schwartz of the Memorial Sloan-Kettering Cancer Center.
MDL Information Systems and Zeneca Renew Partnership
SAN LEANDRO, Calif.--MDL Information Systems, a supplier of chemical and biological information management software and a wholly owned subsidiary of Reed Elsevier, announced that Zeneca Pharmaceuticals has renewed its worldwide license for MDL solutions to increase automation and global information sharing. Scientists in Zeneca's pharmaceutical, agrochemical, and specialty chemicals divisions use MDL's Integrated Scientific Information System, central library, database, and related products. The new agreement will add access to the Life Science Workbench for collecting and analyzing biological data.
With the addition of that product, MDL said Zeneca will be able to link its entire staff of biologists to the system, ensuring that valuable contextual biological data is preserved along with chemical and assay results. Zeneca Research Information Systems Manager Martyn Wilkins said Zeneca determined MDL tools and technology would help "build the robust informatics infrastructure that we need to support the cutting-edge applications we plan for the future."